Compare Stocks → Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (From Paradigm Press) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison OTCMKTS:DGNOFOTCMKTS:LNGLYOTCMKTS:RNUGFOTCMKTS:VIVXFOTCMKTS:WECFY Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDGNOFDIAGNOS$0.21-0.1%$0.21$0.18▼$0.43$16.35M0.224,058 shs42,000 shsLNGLYLiquefied Natural Gas$0.09-10.0%$0.09$0.03▼$0.45$12.98M0.3648,717 shs26,000 shsRNUGFReNeuron Group$0.00$0.04$0.00▼$0.05$63K0.52126 shsN/AVIVXFAvivagen$0.01$0.00$0.00▼$0.02$497K0.12540 shsN/AWECFYWHITE ENERGY CO/S$0.22$0.22$0.22▼$0.29$21.84M2.52150 shsN/AElon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDGNOFDIAGNOS+5.17%-3.96%+21.02%-10.96%-1.93%LNGLYLiquefied Natural Gas0.00%0.00%0.00%0.00%0.00%RNUGFReNeuron Group0.00%0.00%-97.41%-97.86%-98.78%VIVXFAvivagen0.00%0.00%+132.73%+54.22%-69.52%WECFYWHITE ENERGY CO/S0.00%0.00%0.00%0.00%0.00%Exposed: 10 CENT Crypto to Explode April 20th? (Ad)The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…Click For My #1 FREE Crypto for 2024MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDGNOFDIAGNOSN/AN/AN/AN/AN/AN/AN/AN/ALNGLYLiquefied Natural GasN/AN/AN/AN/AN/AN/AN/AN/ARNUGFReNeuron GroupN/AN/AN/AN/AN/AN/AN/AN/AVIVXFAvivagenN/AN/AN/AN/AN/AN/AN/AN/AWECFYWHITE ENERGY CO/SN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDGNOFDIAGNOSN/AN/AN/AN/ALNGLYLiquefied Natural GasN/AN/AN/AN/ARNUGFReNeuron GroupN/AN/AN/AN/AVIVXFAvivagenN/AN/AN/AN/AWECFYWHITE ENERGY CO/SN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDGNOFDIAGNOS$370K44.19N/AN/A($0.02) per share-10.67LNGLYLiquefied Natural GasN/AN/AN/AN/AN/AN/ARNUGFReNeuron Group$640K0.10N/AN/A$0.11 per share0.01VIVXFAvivagen$730K0.68N/AN/A($0.06) per share-0.11WECFYWHITE ENERGY CO/S$1.38M15.82N/AN/A($0.39) per share-0.56Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDGNOFDIAGNOS-$1.88M-$0.04N/A∞N/A-1,553.79%N/A-297.10%N/ALNGLYLiquefied Natural GasN/AN/A0.00∞N/AN/AN/AN/AN/ARNUGFReNeuron Group-$6.52MN/A0.00∞N/AN/AN/AN/AN/AVIVXFAvivagen-$4.71M-$0.04N/A∞N/A-645.05%N/A-716.72%6/4/2024 (Estimated)WECFYWHITE ENERGY CO/S-$7.13MN/A0.00∞N/AN/AN/AN/AN/ALatest RNUGF, DGNOF, WECFY, VIVXF, and LNGLY EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails2/28/2024Q3 2024DGNOFDIAGNOSN/A-$0.01-$0.01-$0.01N/A$0.04 millionDividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDGNOFDIAGNOSN/AN/AN/AN/AN/ALNGLYLiquefied Natural GasN/AN/AN/AN/AN/ARNUGFReNeuron GroupN/AN/AN/AN/AN/AVIVXFAvivagenN/AN/AN/AN/AN/AWECFYWHITE ENERGY CO/SN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDGNOFDIAGNOSN/A0.790.79LNGLYLiquefied Natural GasN/AN/AN/ARNUGFReNeuron Group0.081.51N/AVIVXFAvivagenN/A0.030.02WECFYWHITE ENERGY CO/SN/A0.370.37OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDGNOFDIAGNOSN/ALNGLYLiquefied Natural GasN/ARNUGFReNeuron GroupN/AVIVXFAvivagenN/AWECFYWHITE ENERGY CO/SN/AInsider OwnershipCompanyInsider OwnershipDGNOFDIAGNOSN/ALNGLYLiquefied Natural GasN/ARNUGFReNeuron GroupN/AVIVXFAvivagen2.10%WECFYWHITE ENERGY CO/SN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableDGNOFDIAGNOSN/A76.65 millionN/ANot OptionableLNGLYLiquefied Natural GasN/A144.17 millionN/ANot OptionableRNUGFReNeuron Group2657.17 millionN/ANot OptionableVIVXFAvivagen1377.69 million76.06 millionNot OptionableWECFYWHITE ENERGY CO/SN/A99.26 millionN/ANot OptionableRNUGF, DGNOF, WECFY, VIVXF, and LNGLY HeadlinesNo headlines for this company have been tracked by MarketBeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsDIAGNOSOTCMKTS:DGNOFDIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.Liquefied Natural GasOTCMKTS:LNGLYLiquefied Natural Gas Limited, together with its subsidiaries, engages in the identification and progression of liquefied natural gas (LNG) development projects to facilitate the production and sale of LNG. It operates through LNG Infrastructure, and Technology and Licensing segments. The company's projects include the Magnolia LNG project located in Lake Charles, Louisiana, the United States; and the Bear Head LNG project situated in Point Tupper, Richmond County, Nova Scotia, Canada. It also designs, develops, owns, and patents OSMR LNG liquefaction process. The company is headquartered in Houston, Texas.ReNeuron GroupOTCMKTS:RNUGFReNeuron Group plc researches, develops, and commercializes cell-based therapies in the United Kingdom. The company engages in the development of CTX stem cell therapy candidate for treating stroke disability; and human retinal progenitor cell therapy that is in Phase 2 clinical trial for treating retinitis pigmentosa, a blindness-causing disease. It also develops CTX-derived exosomes that are in the pre-clinical stage, which are Nano-sized vesicles secreted by stem cells. In addition, the company licenses ReNcell products. It has a collaboration agreement with University College London to conduct research into the generation of immune cells from induced pluripotent stem cells for anti-cancer cell therapies. The company was founded in 1997 and is headquartered in Pencoed, the United Kingdom.AvivagenOTCMKTS:VIVXFAvivagen Inc. focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in Canada, Mexico, Brazil, the Philippines, Taiwan, and Thailand. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada.WHITE ENERGY CO/SOTCMKTS:WECFYWhite Energy Company Limited engages in coal technology and exploration businesses in Australia, Indonesia, China, Singapore, South Africa, Mauritius, the United States, and the United Kingdom. The company holds license for the Binderless Coal Briquetting technology, which processes poor quality coal into a higher quality product. It also explores iron oxide-copper-gold-uranium styles of mineralization in tenements near Cooper Pedy, South Australia. White Energy Company Limited is headquartered in Brisbane, Australia. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.